Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Numinus Wellness's Enterprise Value for the quarter that ended in May. 2025 was $8.95 Mil.
Numinus Wellness's EBIT for the trailing twelve months (TTM) ended in May. 2025 was $-9.24 Mil. Numinus Wellness's Earnings Yield (Joel Greenblatt) for the quarter that ended in May. 2025 was -74.63%.
The historical rank and industry rank for Numinus Wellness's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
NUMIF'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -95.24 Med: 0 Max: 0
Current: -75.19
NUMIF's Earnings Yield (Joel Greenblatt) % is not ranked
in the Healthcare Providers & Services industry.
Industry Median: 3.31
vs NUMIF: -75.19
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Numinus Wellness's Forward Rate of Return (Yacktman) % for the quarter that ended in May. 2025 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
Numinus Wellness Earnings Yield (Joel Greenblatt) % Related Terms
Numinus Wellness Earnings Yield (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Numinus Wellness's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Numinus Wellness's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Numinus Wellness Earnings Yield (Joel Greenblatt) % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Numinus Wellness's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Numinus Wellness's Earnings Yield (Joel Greenblatt) % falls into.
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
Numinus Wellnesss Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Aug. 2024 is calculated as
Numinus Wellness's EBIT for the trailing twelve months (TTM) ended in May. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-9.24 Mil.
What does a Earnings Yield (Joel Greenblatt) % of -74.63% mean?
Numinus Wellness (NUMIF) has a Earnings Yield (Joel Greenblatt) % of -74.63% as of May. 2025. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Numinus Wellness and its competitors.
Is Numinus Wellness' Earnings Yield (Joel Greenblatt) % too high?
Numinus Wellness' current Earnings Yield (Joel Greenblatt) % is -74.63%.
How does Numinus Wellness' Earnings Yield (Joel Greenblatt) % compare to HLYK and SYRA?
Numinus Wellness' Earnings Yield (Joel Greenblatt) % of -74.63% can be compared against companies in the Healthcare Providers & Services industry. The industry median Earnings Yield (Joel Greenblatt) % is 3.31. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median Earnings Yield (Joel Greenblatt) % among Healthcare Providers & Services companies is 3.31, based on 688 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Numinus Wellness and its competitors. For the Healthcare Providers & Services industry, the median Earnings Yield (Joel Greenblatt) % is 3.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Numinus Wellness's current Earnings Yield (Joel Greenblatt) % is -74.63%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Numinus Wellness stock overvalued right now?
Numinus Wellness (NUMIF) has a current Earnings Yield (Joel Greenblatt) % of -74.63%. The current Earnings Yield (Joel Greenblatt) % is -74.63%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For Numinus Wellness (NUMIF), the current Earnings Yield (Joel Greenblatt) % is -74.63% as of May. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Numinus Wellness Inc develops proprietary, psychedelic-centered, therapeutic products and services through its laboratory and research & development processes. The company's clinic network consists of Numinus Health, Mindspace Services, and the Neurology Center of Toronto. Its services include Ketamine-assisted psychotherapy for depression, neurological care, psychotherapy, and counseling by registered psychologists among others. The company's operating segments are; Clinical research operations, Canadian clinic network, US clinic network and Corporate. The majority of the revenue for the company is generated from US clinic network segment. Geographically, the company has its presence in United States and Canada.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NUMIF has been successfully added to your 
